ANIP News and Press, ANI Pharmaceuticals Inc. From 06/30/21

ANI's business growth rate could be on the cusp of a rapid acceleration. Free cash flow generation is on the upswing. Stock valuations are pricing in stagnant results, mimicking rear-view mirror thinking. I like the technical chart pattern - a rising price could launch the quo...

The following slide deck was published by ANI Pharmaceuticals, Inc. in conjunction with this event. For further details see: ANI Pharmaceuticals (ANIP) Presents At Raymond James Human Health Innovation Conference 2021 - Slideshow

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Raymond James Human Health Innovation Conference 2021 as follows: ...

ANI Pharmaceuticals, Inc. (“ANI“ or the “Company“) (Nasdaq: ANIP) today announced log-in details for its 2021 Virtual Annual Meeting of Stockholders to be held on June 2, 2021, beginning at 10 a.m. Eastern Time. Stockholders can attend the virtual annual ...

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Jefferies Virtual Healthcare Conference 2021 as follows: The pr...

ANI Pharmaceuticals posted much better quarterly results than expected on Friday. This triggered a 15% rally in the stock that day, which the shares promptly gave back in yesterday's market sell-off. We dig into the numbers and update our investment thesis on this promising biopha...

ANI Pharmaceuticals, Inc. (ANIP) Q1 2021 Earnings Conference Call May 07, 2021 08:30 AM ET Company Participants Lisa Wilson - In-Site Communications, Investor Relations Nikhil Lalwani - President & Chief Executive Officer Stephen Carey - Chief Financial Officer Conference Call Participant...

Image source: The Motley Fool. ANI Pharmaceuticals Inc (NASDAQ: ANIP) Q1 2021 Earnings Call May 7, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: ANI Pharmaceuticals Inc (ANIP) Q1 2021 Earnings Call Transcript

ANI Pharmaceuticals (ANIP): Q1 Non-GAAP EPS of $1.04 beats by $0.33; GAAP EPS of $0.01 beats by $0.29.Revenue of $54.52M (+9.5% Y/Y) beats by $7.72M.Press Release For further details see: ANI Pharmaceuticals EPS beats by $0.33, beats on revenue

-- First quarter 2021 net revenues of $54.5 million; net income of $0.1 million and diluted earnings per share of $0.01 -- -- First quarter adjusted non-GAAP EBITDA of $18.9 million and adjusted non-GAAP diluted earnings per share of $1.04 -- -- Cortrophin ® G...